Startup | August 20, 2021
Navia Life Care raises US $ 1 million in Series A funding
The company plans to invest in technology, business development, product innovation, and development across India
The company plans to invest in technology, business development, product innovation, and development across India
QIAGEN and OncXerna enter into a global master agreement to advance the development of the Xerna TME panel as a potential Next Generation Sequencing (NGS) companion diagnostic for OncXerna’s Navicixizumab
Dr.Reddy's will receive U.S. $6 million upfront upon closing followed by U.S. $9 million one year from closing
This deal makes Meddo, one of the largest health-tech players in India
Sumatriptan Injection USP is indicated in adults for acute treatment of migraine with or without aura, and acute treatment of cluster headache
Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.
Apart from the above, it was also decided that Basic Customs Duty on import of COVID-19 vaccines be also exempted with immediate effect for a period of 3 months
India produces 60% of the world’s vaccine
The resilient attitude of Indian pharmaceutical companies coupled with quick innovative solutions has ensured consistency in supply chains amid unprecedented challenges
Subscribe To Our Newsletter & Stay Updated
